Roche Launches Mesothelioma Differential Diagnosis Test
Roche launched a test for the differential diagnosis of mesothelioma.
Related stories
West Bancorporation Reports Quarterly Results Through September 30
M impact | EQUITY | Oct 29, 2026, 03:00 PM UTC
DoorDash Agrees to Acquire Instacart in Deal Valued at About $17 Billion
DoorDash announced an agreement to acquire Instacart for approximately $17 billion and reported third-quarter results that beat analyst estimates.
H impact | EQUITY | Oct 29, 2026, 02:59 PM UTC
BorgWarner shares fall as sales forecast range narrows and Q3 revenue misses
BorgWarner’s sales forecast top end was trimmed, and third-quarter revenue missed expectations.
M impact | EQUITY | Oct 29, 2026, 02:59 PM UTC
iFunded extends capital increase offer period to Nov. 10
iFunded extended the offer period for its capital increase again, through Nov. 10.
M impact | EQUITY | Oct 29, 2026, 02:59 PM UTC
Canada stocks fall as miner earnings disappoint and Alphabet weighs on tech
Canada's TSX is lower as miner earnings disappoint and Alphabet drags technology shares.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Ibn Al Haytham Hospital Reports Q3 Revenue of 3.1 Million Dinars
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC